Purchase Order 75N91020P00954

The U.S. government awarded a definitive contract valued at $13.6 million to Università Degli Studi Di Milano (performing as Distam), an Italian public research university, for genetic epidemiology research focused on lung cancer and smoking. Awarded on December 18, 2003, with completion scheduled for June 30, 2005, this 8(a) sole source set-aside contract was structured as cost-no-fee, indicating the contractor would be reimbursed for allowable expenses without profit margin. The research was...

This is a federal contract award from the National Cancer Institute, a civilian agency, to Istituto Oncologico Veneto in Italy. The $99,150.00 Firm Fixed Price contract is for the review of tumor, adjacent normal, and nevus remnant samples, as well as DNA extraction from melanoma and other skin lesions collected from Mediterranean populations. The contract does not have a set-aside designation. No subcontractors are mentioned. The contract supports the National Cancer Institute's research and...

This $22,000 firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services, to the University of Genoa in Italy. The contract is for the collection of melanoma DNA samples and associated clinical data over a 6-month period from September 2023 to February 2024 to support cancer research efforts. The University of Genoa, which is a public higher education institution, has been registered in the...

Universita' Degli Studi DI Cagliari, a not-for-profit organization, was awarded a $24,750.00 firm fixed-price purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to provide laboratory testing services for the evaluation of 3-monothiopomalidomide in an animal model of Parkinson's disease L-DOPA induced dyskinesia. The contract does not have a set-aside designation. This award is one of three prime federal contract...

Universita' Degli Studi DI Cagliari (the University) has been awarded a firm fixed price purchase order contract from the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to provide laboratory testing services. The contract has a potential value of $22,000 and a completion date of December 6, 2023. The University will conduct research evaluating drug compounds for Parkinson's disease in animal...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

This is a delivery order contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center (MD Anderson) valued at $658,199.33. The contract is for a phase I dose escalation study of a topical cancer prevention agent, bexarotene, in women at high risk for breast cancer. It is part of the NCI's Cancer Prevention Agent Development Program, an early-phase clinical research initiative. The contract does not have a set-aside designation. MD Anderson is a...

This is a firm fixed-price delivery order awarded by the National Cancer Institute to Metabolon, Inc., a self-certified small disadvantaged business, for a project titled "Bile Acid Concentrations and Development of Liver Cancer in the Liver Cancer Pooling Project (LCPP)-MET Study." The $87,290 contract will support metabolomic profiling research related to molecular epidemiology studies on liver cancer. Metabolon has extensive experience providing specialized metabolomics analysis...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson) under the PREVENT Preclinical Drug Development Program (PREVENT) IDIQ contract. The $1,249,115 award supports a project titled "TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA", which aims to develop a DNA vaccine to prevent the onset of multiple myeloma by targeting the DKK1 protein. This effort falls...

This is a delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for the Fiscal Year 2025 Melanoma Research Program. The contract has a total ceiling value of $245,071.81 and is a cost-plus-fixed-fee type. The contract is not set aside for any specific business categories. The contract provides general program support, pre-application screening, programmatic review, and vision setting for the Melanoma Research Program, which is a Defense Health Agency initiative focused...